Long-term Study of DSP-5423P in Patients With Schizophrenia
NCT02335658
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
DSP-5423P
Sponsor
Sumitomo Pharma Co., Ltd.